ライフサイエンスコーパス: evaluate

1 mia at 47 degrees C (0-780 CEM(43)) has been evaluated.

2 nts (mean age, 69 years +/- 8; 111 men) were evaluated.

3 l of anticancer drugs from 1998 to 2018 were evaluated.

4 ng a previously defined spatial network were evaluated.

5 otal of 771 patients and 1,820 implants were evaluated.

6 occur in virtually all tissues and diseases evaluated.

7 nd all-cause mortality during follow-up were evaluated.

8 r digital subtraction angiography (DSA) were evaluated.

9 tive therapeutic options are currently being evaluated.

10 ycles on circulating BDNF concentrations was evaluated.

11 sus non-surgical therapy alone (control) was evaluated.

12 , the effect of age, sex and laterality were evaluated.

13 acid/alkaline pH-shift protein isolation was evaluated.

14 requency, and number of injections were also evaluated.

15 -isotypic control or (212)Pb-daratumumab was evaluated.

16 and the impact on long-term health is poorly evaluated.

17 taining of information of 3328 patients were evaluated.

18 ds with various forms of cardiomyopathy were evaluated.

19 del discrimination and calibration were both evaluated.

20 e human surgical right atrial specimens were evaluated.

21 100 eyes (62% were female participants) were evaluated.

22 AR-FL or AR-V7 alone or in combination were evaluated.

23 etween initial treatment and PET imaging was evaluated.

24 We evaluated (1) long-term immunogenicity of an initial 2-d

25 MTD was not reached (maximum dose evaluated, 200 mg twice a day); 150 mg once daily was es

26 In a worldwide collaborative effort, we evaluated 231 individuals harboring 105 distinct heteroz

27 We evaluated 296 807 adult (age > 17) solitary kidney trans

28 resh tissues.METHODSThis observational study evaluated 6 individuals with HIV (n = 4 with viral suppr

29 We apply the AWA methodology to evaluate a new diagnostic test developed in the Rapid Di

30 We aimed to evaluate a tailored prescription of affordable digital d

31 We evaluated a series of 127 consecutive unexplained cases

32 ials Archive-ICH trials dataset, Clot Lysis: Evaluating Accelerated Resolution of Intraventricular He

33 Toxicity between treatment and 3 mo was evaluated according to the Common Terminology Criteria f

34 Four registered randomized trials plan to evaluate ACEIs and ARBs for treatment of COVID-19.

35 Performance of the ANN was evaluated against logistic regression and the standard g

36 re the correlation with 18F-GTP1 tau PET was evaluated (Alzheimer's disease = 38, control = 11).

37 This approach provides a new way to evaluate and constrain computational models with brain a

38 ll provide an effective approach to prevent, evaluate and intervene in a fast, affordable and reliabl

39 Dogs in each household were evaluated and owners completed a questionnaire whilst th

40 of an approach that automatically generates, evaluates, and proposes cyclizations utilizing a library

41 Eighty-two Dutch patients with SCA3/MJD were evaluated annually for 15 years using the International

42 f this study was to develop a methodology to evaluate antibiotic use across inpatient and ambulatory

43 ELF was evaluated as a time dependent variable by generating tim

44 c polymer-based monolithic columns have been evaluated as the separation media for analysis of peptid

45 s a nonspecific sign it needs to be properly evaluated as there can be underlying serious illnesses a

46 transform, making it difficult to accurately evaluate associated toxicity responses representative of

47 Pediatric KC cases <18 years of age were evaluated at a tertiary hospital.

48 Hemodynamics were evaluated at baseline, after pulmonary embolism and afte

49 terleukin-2, and CD40 ligand) responses were evaluated at month 6.5 for all participants and at month

50 Evaluating ATM phenotype and intracellular metabolism to

51 We then evaluated autoimmune disease parameters, kidney disease,

52 , lead impedance, and capture threshold were evaluated before and immediately after (within 10 minute

53 onic social defeat stress (CSDS) in mice and evaluated behavior with PsychoGenics' SmartCube, a high-

54 of scientific and regulatory approaches for evaluating bioactivity.

55 PersAFOne is a single-arm study evaluating biphasic, bipolar PFA using a multispline cat

56 (2018) using criteria that also evaluated bleeding upon probing.

57 The study evaluates both functional and anatomical outcomes of ret

58 ferent PET reconstructions was independently evaluated by 3 experts.

59 Ninety-day outcomes were evaluated by blinded telephone interviewers.

60 Interobserver agreement was evaluated by calculating weighted kappa coefficients.

61 hygiene effectiveness (dental calculus) were evaluated by calibrated dentists through oral examinatio

62 ed at week 12 and the augmented tissues were evaluated by cone-beam computed tomography, microcompute

63 gression-free survival (PFS; by RECIST) were evaluated by Cox regression and Kaplan-Meier statistics.

64 s aerosolized dry powders was systematically evaluated by design of experiments (DOEs) using three di

65 extensive neurite outgrowth and branching as evaluated by immunocytochemistry of neuronal markers.

66 se tissue biopsies, changes in fibrosis were evaluated by immunohistological examination and by the e

67 models, including six other algorithms, was evaluated by internal 5-fold cross-validation statistics

68 GNP-HCIm cytotoxicity was evaluated by MTT assay, apoptosis/necrosis and phosphory

69 tic factors with cardiovascular dynamics, as evaluated by phase coherence.

70 racted directly from oropharyngeal swabs and evaluated by quantitative reverse transcription-PCR (qRT

71 of 500 chest radiographs in 500 patients was evaluated by the CV19-Net and three experienced thoracic

72 ilometer run test, and anaerobic fitness was evaluated by the numbers of sit-ups and push-ups perform

73 MR venography images were evaluated by three radiologists for presence of stenosis

74 Accuracy was evaluated by using the Dice similarity coefficient (DSC)

75 tive OPM2 multiple myeloma cells was used to evaluate CD38-specificity of (89)Zr-DFO-daratumumab.

76 ciated with milder phenotype for most of the evaluated clinical outcomes, including age at loss of am

77 Animals were evaluated clinically on a daily basis during a 20-day ex

78 Purpose To evaluate configurations of deep convolutional neural net

79 MYCN-driven disease, with limited ability to evaluate conventional pharmacodynamic biomarkers of resp

80 Here, we evaluated CVac regimens using primaquine and/or chloroqu

81 novel statistical approach to systematically evaluate deleterious DNMs in inherited cancer syndromes.

82 A chi(2) test was used to evaluate differences.

83 The objective of this study was to evaluate different strategies for adding 3% black quinoa

84 Neurologic toxicity was evaluated during an 8-month surveillance: no overt const

85 actors associated with user satisfaction and evaluate each scenario's resource recovery potential, ec

86 co products other than cigarettes; no trials evaluated effects of interventions on e-cigarette use.

87 mography scan and were thereafter clinically evaluated every 2-4 months (years 1-2), then every 6 mon

88 The presence of chronic PAMM lesions was evaluated for both eyes by the revision of cross-section

89 ied to group lasso-selected metabolites were evaluated for classifying case status.

90 These lines were evaluated for SD measured by germination at 7, 21, 35, a

91 te Response and 11 Progressive Disease) were evaluated for serum SEVs size, concentration and screene

92 The sensor was also evaluated for the determination of the two mycotoxins in

93 arious preblocking or displacing agents were evaluated for their impact on the PET brain imaging data

94 of 180, 360 and 540 W for 5 and 10 min were evaluated for their influence on oil yield, chemical pro

95 on alone and together with lecithin (L) were evaluated for their inhibition against the formation of

96 it) ) and the initial response (m(1) ), were evaluated for their usability for forecasting adult heat

97 usceptibility testing for all patients being evaluated for tuberculosis (TB), a lack of rapid diagnos

98 Evaluating for non-pharmacologic approaches to managing

99 MBF was evaluated from images with and without attenuation corre

100 t centre reported satisfactory Short Form-36 evaluated health-related quality of life at 1-year follo

101 linkage disequilibrium score regression and evaluated heritability enrichment in 64 genome-wide asso

102 and difference-in-differences regression to evaluate how WIC authorization affected sales of WIC-eli

103 ion after 1-3 years on a gluten-free diet to evaluate improvements in villous atrophy.

104 his end, we used data from 415 maize hybrids evaluated in 4 years of second season field trials for t

105 st-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment

106 The diagnostic utility of tau368 was first evaluated in a pilot study (Alzheimer's disease = 20, co

107 DNAN reduction in the presence of RDX was evaluated in abiotic experiments using substoichiometric

108 ripple and fast ripple frequency ranges were evaluated in both conditions, and their rate, spectral e

109 Avadomide is being evaluated in combination with other antilymphoma agents.

110 rs of Aurora A and mTOR, are currently being evaluated in early phase clinical trials in children wit

111 Estrogen-Receptor Partial Agonists are being evaluated in endocrine-resistant BC clinical trials.

112 Assay performance was evaluated in four clinic-based prospective cohorts.

113 In vivo, m-RCT was evaluated in mouse models of hypercholesterolemia that w

114 AB680 is currently being evaluated in phase 1 clinical trials.

115 h frameworks perform far less favorably when evaluated in their ability to generalize or transfer rep

116 H4-PEG-PT has been further evaluated in vivo and exhibited strong tumor uptake, spe

117 biodistribution (antigen and adjuvant) were evaluated in vivo.

118 mes and nitrogen deposition, yet few studies evaluate interactions among these changing conditions.

119 Prediction performance was evaluated internally (in the CCSS cohort) and externally

120 etail from small-matrix MRI acquisitions and evaluate its performance against that of conventional im

121 The findings support a phase 2a study to evaluate JNJ-6379 +/- nucleos(t)ide analogs in patients

122 The objectives of the present study are to evaluate levels of mercury, cadmium, lead, and arsenic i

123 phy is the first-choice imaging technique to evaluate liver transplants.

124 This study aimed to evaluate longitudinal changes in retinal blood flow in r

125 sive estimate of the actual diversity in the evaluated materials.

126 We use it to evaluate mechanisms promoting coexistence between two co

127 ts (DBS) though more research is required to evaluate mercury (Hg) speciation in DBS and to validate

128 We evaluated MirCure on a set of manually curated animal an

129 We evaluated MIXnorm through simulations and cancer studies

130 teractive application in MATLAB to build and evaluate ML algorithms for the prediction of postoperati

131 Studies evaluating MRI accuracy with a pragmatic algorithm and p

132 We evaluated multivariable-adjusted associations with IOP u

133 ctroscopy (NMR) with the aim of building and evaluating multivariate statistical models and machine l

134 Symptom network analysis was conducted to evaluate network and bridge centrality, and the network

135 Purpose To evaluate neurodevelopmental outcomes, gray matter volume

136 Construct validity was evaluated on a sample of 120 patients who underwent lapa

137 We aim to evaluate outcomes in a prospective study of anomalous ao

138 We evaluated outcomes among survivors of early-adolescent a

139 This study evaluates outcomes of comparable pseudophakic rhegmatoge

140 ead of 4 ARO species across regional NFs and evaluated patient-level characteristics and transfer acu

141 We sought to evaluate patients at a single academic institution in a

142 The EBBINGHAUS (Evaluating PCSK9 Binding Antibody Influence on Cognitive

143 construct a Social Distancing Index (SDI) to evaluate people's mobility pattern changes along with th

144 e observational study established in 2006 to evaluate perinatal outcomes in pregnant women exposed to

145 er prospective studies are needed to further evaluate possible enhancements to the current scoring sy

146 We evaluated post-LT outcomes, predictors of down-staging,

147 xplore power and sample-size calculations to evaluate potential correlates of risk during an Ebola va

148 va L.) and wheat (Triticum aestivum L.), and evaluates potential risks associated with their consumpt

149 antagonists in patients with advanced HCC by evaluating potential resistance mechanisms to AR-targete

150 We evaluated power of Alive and Ventilator Free versus vent

151 We evaluated pre-HD stratification models based on single v

152 trials and prospective observational studies evaluating pre and post-procedure hormones fasting ghrel

153 We aimed to evaluate prevalence, staging and clinical features corre

154 review analyses the evidence from rigorously evaluated programmes that seek to transform the gendered

155 cipients, and we used bioinformatic tools to evaluate protein abundance and functional category enric

156 Few studies have evaluated RDV in patients with SRI due to theoretical to

157 We sought to evaluate relationships between classroom NO(2) exposure

158 We sought to evaluate safety and efficacy of the JAK1/2 inhibitor rux

159 We also evaluate SemRep on two datasets.

160 We evaluated serum biomarkers in 149 individuals; 77 (52%)

161 APF with any evaluated soft tissue graft was associated with with red

162 ncement is the imaging modality of choice to evaluate sonographically indeterminate adnexal masses.

163 nt protective effect and was not designed to evaluate source control.

164 tomic, sphingolipid, and protein analyses to evaluate sphingolipid metabolism and signaling post-MI.

165 We evaluated Streptomyces biogeography in soils along a 120

166 under different environmental conditions to evaluate support for different selective pressures in dr

167 parents and during cohousing experiments and evaluated susceptibility to oral inflammatory disease in

168 ere performed with the NanoSPECT/CT(PLUS) to evaluate system energy resolution, count rate performanc

169 Here, we evaluate TDF and FTC in combination with the broadly neu

170 perating characteristic analysis was used to evaluate the ability of IFV diameter to help predict PAS

171 To provide a marker of performance, we evaluate the accuracy of primary care physicians to cate

172 ne expression analysis use simulated data to evaluate the accuracy of these methods.

173 The aim of the study was to evaluate the activity of FAP via FAPI-positron emission

174 To evaluate the activity of oligodendrocyte NMDARs and alph

175 The aim of this study was to evaluate the associations between ADHD polygenic risk sc

176 The current study was carried out to evaluate the bioactive constituents and physical propert

177 To evaluate the bleaching ability, the effect on enamel sur

178 of reducing molecules in vivo, as well as to evaluate the change in (64)Cu-ATSM signal after redox-ac

179 The test group was used to evaluate the classifier for sensitivity, specificity, po

180 We aimed to evaluate the clinical and genetic prevalence of lipodyst

181 The aim of this study was to evaluate the cost-effectiveness of implementing a stepwi

182 This study sought to evaluate the demographic profile, clinical features, top

183 In order to evaluate the different classes of experiment for studies

184 e binding of [(3)H]muscimol has been used to evaluate the distribution of GABA(A) receptors in the br

185 This study aimed to evaluate the effect of flow rate on prognostic value of

186 on specific patient profiles.Objectives: To evaluate the effect of OSA on cardiovascular risk for pa

187 cies on economic growth(5,6), to empirically evaluate the effect that these anti-contagion policies h

188 mics, and help better allocate resources and evaluate the effectiveness of future inventions.

189 We aimed to evaluate the effectiveness of reactive focal mass drug a

190 controversial.Objectives: To comprehensively evaluate the effects of rare SERPINA1 variants on lung f

191 We aimed to evaluate the efficacy and safety of ixekizumab, an IL-17

192 Longer and larger trials are necessary to evaluate the efficacy and safety of sodium phenylbutyrat

193 The goal of this work is to evaluate the efficacy of machine learning algorithms to

194 andomized and double-blind clinical trial to evaluate the efficacy of miltefosine combined with topic

195 sed upper airway collapsibility of DS and to evaluate the efficacy of therapeutic interventions for b

196 The aim of this study was to systematically evaluate the efficacy, outcomes, and complications of ga

197 hierarchical mixed-model approach, we first evaluate the environmental pressures affecting invertebr

198 gative predictive value, and accuracy and to evaluate the estimator for correlation, bias, limits of

199 nial magnetic stimulation (TMS) protocols to evaluate the excitation index, a biomarker reflecting th

200 rospective interventional case series was to evaluate the feasibility and effectiveness of using the

201 tion of normalized epithelium.Objectives: To evaluate the feasibility, safety, and initial outcomes o

202 Here, we evaluate the growth of genetically defined renal tumors

203 ing genotypes (HP1-1 and HP2-1) and HP2-2 to evaluate the HP1 allele.

204 We describe 156 cases over 5 years and evaluate the impact of clinical interventions using viro

205 In this study, we sought to evaluate the impact of implantable cardiac monitoring (I

206 Thus, the aim of this study was to evaluate the impact of soft tissue grafting procedures c

207 To evaluate the in vivo efficacy of (212)Pb-daratumumab, mi

208 To evaluate the influence of automated visual field (VF) te

209 dergoing fecal microbiota transplantation to evaluate the patterns of acquisition, transmission and s

210 port three Turing-inspired tests designed to evaluate the performance of molecular generators.

211 We evaluate the performance of our Bayesian inference proce

212 We evaluate the performance of our measures using extensive

213 The aim of the present study was to evaluate the performance of this method in a multicenter

214 Here, we evaluate the phylogenetic relationships of the SEC14L-PI

215 Using these genetic data, we evaluate the population genetic structure of historical

216 In this review, we evaluate the possibility that the hormone ghrelin may co

217 This study sought to prospectively evaluate the predictive ability of nGA for the conventio

218 l Method Validation Guidance for Industry to evaluate the quality of the assay.

219 This study aims to evaluate the readability (grade level) and suitability (

220 The aim was to evaluate the relation of prepregnancy adherence to the A

221 Mouse models of cervical cancer were used to evaluate the relationship between (64)Cu-ATSM signal and

222 self-controlled case series (SCCS) design to evaluate the relative incidence of deaths with respirato

223 ng a tool that will allow decision-makers to evaluate the relative risk of different shipping routes.

224 We aimed to evaluate the safety, tolerability, and antitumour activi

225 lized knockin and transgenic mouse models to evaluate the structural, functional and biochemical effe

226 Here, to evaluate the utility of circulating tumor DNA (ctDNA) ge

227 We sought to evaluate the visual, refractive, and biomicroscopic find

228 The objective of this study was to evaluate the volatile composition and the sensory effect

229 ivation of the SARS-CoV-2 S glycoprotein, we evaluated the ability of protease inhibitors to suppress

230 Twenty-five studies (n = 15 785) evaluated the accuracy of screening tests; across indivi

231 We refined the structure of DDM and evaluated the activity of novel congeners in triple nega

232 No prospective studies have evaluated the associations between different types of pl

233 a cohort of black and white young adults, we evaluated the associations of E-selectin and ICAM-1, obt

234 This study evaluated the cost-effectiveness of implementing nationa

235 hat facilitates diagnostic-quality scans and evaluated the diagnostic performance and safety in a pha

236 This study evaluated the effect of Msx2-null mutation during experi

237 c reviews (SRs) and meta-analyses (MAs) have evaluated the effect of periodontal treatment on systemi

238 Here, we evaluated the effect of substrate on nest removal by hum

239 the isolated canine gastrocnemius model, we evaluated the effects of acute nitrite infusion on muscl

240 We evaluated the factors associated with survival time in a

241 ng to Augment PrEP Pill Taking (ADAPT) Study evaluated the feasibility of daily and nondaily human im

242 In the present study, we evaluated the feasibility of fabricating grapefruit-peel

243 We evaluated the impact of maternal HIV infection on the bu

244 A general linear model evaluated the interactions between maternal SDB and offs

245 We evaluated the occupancy of the kappa opioid receptor (KO

246 cute Coronary Syndromes) trial (NCT02061891) evaluated the outcome of patients with confirmed NSTEACS

247 We evaluated the performance of the biggest AWL-reactor to

248 In this study, we evaluated the propensity of a 2010.1 H3N2 IAV (A/swine/O

249 sp1772 to Ala) into a murine coronavirus and evaluated the replication and pathogenesis of the DUB mu

250 We then evaluated the reproducibility of these ICNs in an indepe

251 This study evaluated the risk and risk factors for exudative retina

252 Here, we developed and evaluated the rolling circle amplification (RCA) product

253 effects of mesenchymal stem cell (MSCs), we evaluated the safety and efficacy of an allogenic MSC-ba

254 Our recent study evaluated the transcriptomic response occurring in rice

255 re risk in patients receiving osimertinib by evaluating the available data.

256 Randomized, controlled trials evaluating the clinical efficacy of PCCs in patients wit

257 ment in providing effective intervention and evaluating the effectiveness of intervention.

258 Data evaluating the implantable cardioverter defibrillator (I

259 his single-academic-center prospective study evaluating the positivity rate of (18)F-DCFPyL PET/CT in

260 we present several performance measures for evaluating the quality of a set of markers when there is

261 ding treatment, detecting complications, and evaluating the response to treatment.

262 Evaluating the risk of progression using naive CD4+ T-ce

263 he effect of verubecestat on brain volume by evaluating the time course of volumetric MRI changes for

264 ximately 4000 generic drugs and drug classes evaluated, the method detected 19 distinct drug exposure

265 Kidney Allograft Function (DeKAF) study were evaluated: The Prospective Cohort (PC, n=581): Patients

266 ng on the contents of these elements, and to evaluate their bioaccessibility in the mushrooms ready f

267 ding persons with a family history of HNC to evaluate their risks.

268 t basic semiology and answered two questions evaluating their degree of confidence in interpreting ul

269 ling pathways is the essential first step in evaluating their therapeutic potential.

270 We evaluated these antigens by enzyme-linked immunosorbent

271 We evaluated these claims using Arabidopsis (Arabidopsis th

272 We evaluated this association in a prospective birth cohort

273 In the present study, we evaluated tissue SPP1 mRNA and OPN protein expression as

274 These data have been evaluated to provide practical considerations for the as

275 ood frequency questionnaires (2009-2012), we evaluated total caffeine intake.

276 We further evaluated transmissibility of oral microbiomes from pare

277 Our larger, more resolved, and better-evaluated TWiG-based hypothesis supports the grouping of

278 The augmented database was evaluated using (i) a panel of nine control strains and

279 AI predictions were evaluated using 10-fold cross-validation against annotat

280 ine, and cementoblast proliferation was then evaluated using a real-time cell analyzer for 142 hours.

281 ly found to be effective in treating HS, was evaluated using a subcutaneous formulation in patients w

282 ollection efficiency of the microchannel was evaluated using different-sized standard polystyrene-lat

283 etric rate of torque development values were evaluated using isokinetic dynamometry.

284 on-free (PFS) and overall survival (OS) were evaluated using log-rank tests and Cox proportional haza

285 elling on the size of EVs was systematically evaluated using nanoparticle tracking analysis (NTA), wh

286 In this study, we evaluated vitamin D and mineral (iron, zinc, magnesium)

287 Of the 23 nucleoporins evaluated, we observed a reduction in a subset of 8, inc

288 prevent BPD or PH is unknown.Objectives: To evaluate whether postnatal treatment with rhIGF-1 (recom

289 The second objective was to evaluate whether preclinical mutation carriers demonstra

290 Future studies should evaluate whether resuscitation aimed at closing the CO2

291 This report evaluated whether irritability is associated with SI at

292 It also evaluated whether smell or taste loss are indicative of

293 icles on cell proliferation and toxicity was evaluated, which clearly showed a synergic action of TMZ

294 stigational antigens which are being further evaluated with a large cohort of blinded samples from th

295 r of postoperative complications and FTR was evaluated with multivariable logistic regression.

296 s such as texture, drip loss and colour were evaluated with thawed samples.

297 actable insomnia undergoing PCSL (n=20) were evaluated with the Pittsburgh Sleep Quality Index (PSQI)

298 uptake, outcome, and HCV RNA prevalence were evaluated, with follow-up through May 2018 (median follo

299 Follow-up samples were studied to evaluate within-patient clustering stability in patients

300 We evaluated XDR-LFC performance with 87 phenotypically and